⭐ Top Story
Psychedelics and Cannabis: A Look at the Converging Investment Landscape
Sheeba explores the growing convergence between the cannabis and psychedelics sectors. Both industries face similar regulatory hurdles and market development challenges. Investment opportunities…
📈 Top Movers
Top 3 Undervalued Cannabis Stocks to Watch This Month
Sheeba highlights three cannabis stocks with significant upside potential. These companies show strong fundamentals, strategic growth initiatives, and favorable market positions, making them…
Trulieve Q4 2025: Record Cash Flow Signals Market Strength
Trulieve Cannabis reports strong Q4 earnings with record cash flow generation, proving cannabis retail can thrive at scale.
GTI Boosts Borrowing by $50 Million
Green Thumb Industries (GTI) increased its borrowing capacity by $50 million, strengthening its balance sheet for growth and operations.
Curaleaf Borrows $500 Million for 3 Years at 11.5%
Curaleaf secured a $500 million three-year loan at 11.5% interest, adding liquidity for expansion and debt management in a high-rate environment.
Canopy Growth: When Dilution Disguises Desperation
Canopy Growth’s capital raises via warrant issuances continue a troubling pattern: the company dilutes existing shareholders to fund acquisitions that have failed to generate returns. Investors…
Canopy Growth Technical Analysis: Dead Cat or Bounce?
Canopy Growth’s recent price action shows classic dead-cat bounce characteristics. At $1.12, the stock is testing resistance that has failed multiple times over the past 18 months. Technical traders…
📰 Today's News
2026 Cannabis M&A Forecast: Who Acquires, Who Gets Bought, Who Survives Alone
M&A velocity rising. Big players (GTI, CURLF, Trulieve) buying regional chains. Small pure-plays face: get acquired, merge, or die.
Schedule III Reclassification Timeline: What We Know (And What We Don’t)
DEA comment period ends late March 2026. Implementation Q3 2026. Financial sector access in 2027. Position for 2027 tailwind now.
Cannabis ETF Rebalance: Why March Is Critical for Stock Movements
Cannabis ETF rebalancing creates predictable 2-4 week momentum window. CURLF and CGC likely beneficiaries this month.
Why Cannabis Retail Consolidation Is Actually Good News for Investors
13% license contraction = ruthless elimination of low-quality operators. Survivors = pure-play winners with real unit economics.
Cannabis Banking Breakthrough: Federal Reform Accelerating Faster Than Expected
Federal banking reforms moving ahead of schedule. SAFE Act momentum building. GTI and CURLF positioned to benefit immediately.
Psychedelics and Cannabis: A Look at the Converging Investment Landscape
Sheeba explores the growing convergence between the cannabis and psychedelics sectors. Both industries face similar regulatory hurdles and market development challenges. Investment opportunities…